Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Open accessThe DOI matches its Crossref record; 621 of the 628 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected women have marked insulin resistance, independent of obesity. This article summarizes the state of the science since we last reviewed the field in the Endocrine Reviews in 1997. There is general agreement that obese women with PCOS are insulin resistant, but some groups of lean affected women may have normal insulin sensitivity. There is a post-binding defect in receptor signaling likely due to increased receptor and insulin receptor substrate-1 serine phosphorylation that selectively affects metabolic but not mitogenic pathways in classic insulin target tissues and in the ovary. Constitutive activation of serine kinases in the MAPK-ERK pathway may contribute to resistance to insulin's metabolic actions in skeletal muscle. Insulin functions as a co-gonadotropin through its cognate receptor to modulate ovarian steroidogenesis. Genetic disruption of insulin signaling in the brain has indicated that this pathway is important for ovulation and body weight regulation. These insights have been directly translated into a novel therapy for PCOS with insulin-sensitizing drugs. Furthermore, androgens contribute to insulin resistance in PCOS. PCOS may also have developmental origins due to androgen exposure at critical periods or to intrauterine growth restriction. PCOS is a complex genetic disease, and first-degree relatives have reproductive and metabolic phenotypes. Several PCOS genetic susceptibility loci have been mapped and replicated. Some of the same susceptibility genes contribute to disease risk in Chinese and European PCOS populations, suggesting that PCOS is an ancient trait.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin resistance and hyperinsulinemia, either directly or indirectly, through factors such as adiposity can lead to increase circulating androgen levels (6).”
From Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis (2025) · cites this paper as [6]
In the citing paper
“Androgen excess favors visceral fat deposition and lipid dysfunction with a vicious cycle of worsening of hyperinsulinemia and insulin resistance (6).”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [6]
In the citing paper
“primarily due to hyperinsulinemia resulting from insulin resistance, which increases ovarian androgen production [162, 163].”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [163]
In the citing paper
“Moreover, women who have both obesity and PCOS exhibit a greater level of insulin resistance in comparison to obese persons who do not have PCOS [53].”
In the citing paper
“Consensus is yet to be achieved in lean women with PCOS as IR is not consistently demonstrated (Diamanti-Kandarakis and Dunaif, 2012).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Diamanti-Kandarakis and Dunaif, 2012
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Research works printed but not linked: 5
- Achard, 1921, Le virilisme et son association à l'insuffisance glycolytique (diabète des femmes à barbe), Bull Acad Natl Med (Paris), 86, 51
- Vague, 1947, La différentiation sexuelle. Facteur determinant des formes de l'obesité, Presse Med, 55, 339
- Chereau, 1844, Mémoires pour servir à l'étude des malades ovaires
- Givens, 1992, Historical Overview of the Polycystic Ovary, 3
- Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome; towards a rational approach, 377
Cited by
Items 301–400 of 1,006
Maliqueo, M. A., Benrick, A., & Stener‐Victorin, E. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371090 · Cited by 65
MicroRNAs related to androgen metabolism and polycystic ovary syndrome
Sørensen, A. E., Udesen, P. B., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.008 · Cited by 65
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus
Zhang, Y., Sun, X., Sun, X., Meng, F., Hu, M., Li, X., Li, W., Wu, X., Brännström, M., Shao, R., et al. (2016) · Scientific Reports · doi:10.1038/srep30679 · Cited by 66
Christ, J. P., Gunning, M. N., Meun, C., Eijkemans, M. J. C., van Rijn, B. B., Bonsel, G. J., Laven, J. S. E., & Fauser, B. C. J. M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01787 · Cited by 66
Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
Asfari, M. M., Sarmini, M. T., Baidoun, F., Al‐Khadra, Y., Ezaizi, Y., Dasarathy, S., & McCullough, A. J. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000352 · Cited by 65
Fisiopatología y alteraciones clínicas de la diabetes mellitus tipo 2: revisión de literatura
Fernández, C. I. J., Pereira, Y. A. M., Chang, A. S. O., Olmedo, S. I. G., & Gaete, M. C. A. (2022) · Nova · doi:10.22490/24629448.6184 · Cited by 69
Mukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 66
Nutritional guidelines for the management of insulin resistance
Muscogiuri, G., Barrea, L., Caprio, M., Ceriani, F., Chavez, A. O., El Ghoch, M., Frias-Toral, E., Mehta, R. J., Mendez, V., Paschou, S. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1908223 · Cited by 63
“Constitutive activation of serine kinases in the MAPK- ERK pathway in skeletal muscle cells has been related to IR in PCOS (Diamanti-Kandarakis and Dunaif 2012).”
BackgroundInfluentialPolycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation
Dumesic, D. A., Padmanabhan, V., Chazenbalk, G. D., & Abbott, D. H. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00878-y · Cited by 63
Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS
Zheng, S.-H., & Li, X.-L. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1111327 · Cited by 63
“(clinical and bio-chemical), PCOS is also associated with IR [18,19].”
BackgroundThe epigenetic correlation among ovarian cancer, endometriosis and PCOS: A review
Throwba, H., Unnikrishnan, L., Pangath, M., Vasudevan, K., Jayaraman, S., Li, M., Iyaswamy, A., Palaniyandi, K., & Gnanasampanthapandian, D. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103852 · Cited by 63
Pililis, S., Lampsas, S., Kountouri, A., Pliouta, L., Korakas, E., Livadas, S., Thymis, J., Peppa, Μ., Kalantaridou, S., Oikonomou, E. K., et al. (2024) · Medicina · doi:10.3390/medicina60101656 · Cited by 65
Pertyńska−Marczewska, M., Diamanti‐Kandarakis, E., Zhang, J., & Merhi, Z. O. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.010 · Cited by 64
“It is well established that almost two thirds of women with PCOS are predisposed to developing IR [66] and ultimately diabetes [67–69], both of which are typically exacerbated by obesity [70,71].”
BackgroundSelf-citationEndocrine and metabolic characteristics in polycystic ovary syndrome.
Glintborg, D. (2016) · University of Southern Denmark Research Portal (University of Southern Denmark) · Cited by 63
Inositols in the Treatment of Insulin-Mediated Diseases
Muscogiuri, G., Palomba, S., Laganà, A. S., & Orio, F. (2016) · International Journal of Endocrinology · doi:10.1155/2016/3058393 · Cited by 56
“This derangement is responsible for androgen excess [27].”
BackgroundGlintborg, D., Petersen, M. H., Ravn, P., Hermann, A. P., & Andersen, M. (2016) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12964 · Cited by 51
“The majority of women with PCOS are insulin-resistant (3).”
BackgroundInfluentialTherapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Li, J., Bai, L., Wei, F., Zhao, J., Wang, D., Xiao, Y., Yan, W., & Wei, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00661 · Cited by 64
Luque-Ramírez, M., Nattero-Chávez, L., Ortiz Flores, A. E., & Escobar-Morreale, H. F. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx039 · Cited by 62
Gluconeogenesis Flux in Metabolic Disease
Shah, A. M., & Wondisford, F. E. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061121-091507 · Cited by 62
Song, X., Shen, Q., Fan, L., Yu, Q., Jia, X., Sun, Y., Bai, W., & Kang, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24190 · Cited by 59
“Decreased insulin-stimulated glucose transport in skeletal muscle has been shown to be a major contributing factor to IR in patients with T2D and obesity.”
BackgroundInfluentialObesity and insulin resistance in children
Tagi, V. M., & Chiarelli, F. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000913 · Cited by 62
“The aetiology of insulin resistance in PCOS is complex and may depend on several genetic [77] and nongenetic sources.”
BackgroundAdvancements in lead therapeutic phytochemicals polycystic ovary syndrome: A review
Luo, E., Jiang, H., Chen, W., Wang, Y., Tang, M., Guo, W., Diao, H., Cai, N.-Y., Yang, X., Bian, Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1065243 · Cited by 62
“, 2020), insulin resistance (Diamanti-Kandarakis and Dunaif, 2012; Azziz et al., 2016), hyperinsulinemia (Housman and Reynolds, 2014; Muscogiuri et al.”
BackgroundThe role of the thyroid in polycystic ovary syndrome
Fan, H., Ren, Q., Sheng, Z., Deng, G., & Li, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1242050 · Cited by 61
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa108 · Cited by 60
Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
Rodgers, R. J., Avery, J. C., Moore, V. M., Davies, M. J., Azziz, R., Stener-Victorin, E., Moran, L. J., Robertson, S. A., Stepto, N. K., Norman, R. J., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0502 · Cited by 60
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00987 · Cited by 60
Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism
Chen, H., Deng, C., Meng, Z., & Meng, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.956772 · Cited by 61
Cloix, L., Reverchon, M., Cornuau, M., Froment, P., Ramé, C., Costa, C., Froment, G., Lecomte, P., Chen, W., Royère, D., et al. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.120410 · Cited by 59
“In granulosa-lutein cells isolated from ovaries of women with classic PCOS, insulin action on glucose metabolism is significantly decreased, whereas insulin action on steroidogenesis is unchanged compared with granulosa-lutein cells from control women [59, 60].”
ResultUjvári, D., Jakson, I., Babayeva, S., Salamon, D., Réthi, B., Gidlöf, S. B., & Hirschberg, A. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171004 · Cited by 60
Which origin for polycystic ovaries syndrome: Genetic, environmental or both?
Fénichel, P., Rougier, C., Hiéronimus, S., & Chevalier, N. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.04.024 · Cited by 61
Kazemi, M., Pierson, R. A., Lujan, M. E., Chilibeck, P. D., McBreairty, L. E., Gordon, J. J., Serrao, S. B., Zello, G. A., & Chizen, D. R. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.11.026 · Cited by 50
Shishehgar, F., Mirmiran, P., Rahmati, M., Tohidi, M., & Ramezani Tehrani, F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0420-1 · Cited by 59
Alebić, M. Š., Bulum, T., Stojanović, N., & Duvnjak, L. S. (2014) · Endocrine · doi:10.1007/s12020-014-0182-5 · Cited by 59
“independent association of overweight/obesity (BMI≥25 kg/m(2)), PCOS (the Rotterdam criteria) and abdominal obesity (WC≥80 cm) with IR demonstrated in this study corroborates the role of intrinsic, PCOS-specific IR [6,11,12].”
BackgroundMethodResultInfluentialNew perspectives on the definition and management of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0832-1 · Cited by 59
“In addition, in the muscles, androgen excess favors an increase in the number of less sensitive type IIb cells and the inhibition of muscle glycogen synthase [79, 80].”
BackgroundAltered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS
Unfer, V., Dinicola, S., Laganà, A. S., & Bizzarri, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197157 · Cited by 50
“Moreover, in a subgroup of PCOS women, increased insulin triggers LH receptor expression on granulosa cells of a subpopulation of small follicles, leading to premature terminal differentiation and arrest of follicular growth that may lead to anovulation [7].”
BackgroundLizneva, D., Atabiekov, I., & Azziz, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64517-8 · Cited by 59
Low Circulating Adiponectin Levels in Women with Polycystic Ovary Syndrome: An Updated Meta-Analysis
Li, S., Huang, X., Zhong, H., Peng, Q., Chen, S., Xie, Y., Qin, X., & Qin, A. (2014) · Tumor Biology · doi:10.1007/s13277-013-1595-0 · Cited by 58
Jiang, B., Xue, M., Xu, D., Song, J., & Zhu, S. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14753 · Cited by 58
Arya, S., Hansen, K. R., Peck, J. D., & Wild, R. A. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.048 · Cited by 59
Roles of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome
Koike, H., Harada, M., Kusamoto, A., Xu, Z., Tanaka, T., Sakaguchi, N., Kunitomi, C., Azhary, J. M. K., Takahashi, N., Urata, Y., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124405 · Cited by 58
Zhang, Y., Han, S., Liu, C., Zheng, Y., Li, H., Gao, F., Bian, Y., Liu, X., Liu, H., Hu, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36680-0 · Cited by 59
Mumm, H., Jensen, D. M., Sørensen, J. A., Andersen, L. L. T., Ravn, P., Andersen, M., & Glintborg, D. (2015) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12545 · Cited by 53
“important predictors of metabolic risk in PCOS (5).”
BackgroundPolycystic ovarian syndrome: clinical and biological diagnosis
Bachelot, A. (2016) · Annales de biologie clinique · doi:10.1684/abc.2016.1184 · Cited by 58
Metabolic Syndrome in Polycystic Ovary Syndrome
Pasquali, R. (2018) · Frontiers of hormone research · doi:10.1159/000485995 · Cited by 58
Yilmaz, B., Vellanki, P., Ata, B., & Yildiz, B. O. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.024 · Cited by 50
Gainder, S., Sachdeva, G., Suri, V., Sachdeva, N. K., & Chopra, S. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_637_18 · Cited by 58
“This risk is higher than in the general population.[21]”
BackgroundMethodInsulin Resistance Adversely Affect IVF Outcomes in Lean Women Without PCOS
Wang, H., Zhang, Y., Fang, X., Kwak-Kim, J. Y.-H., & Wu, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.734638 · Cited by 59
Paul, T., Satyaraddi, A., Cherian, K., Kapoor, N., Kunjummen, A., Kamath, M., & Thomas, N. (2019) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_2_19 · Cited by 57
“Women with features of hyperandrogenism represent a more severe phenotype of PCOS, which is metabolically unhealthy because hyperandrogenism has also been related to obesity.[31]”
Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models
Roland, A. V., & Moenter, S. M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.002 · Cited by 57
Fouqueray, P., Bolze, S., Dubourg, J., Hallakou‐Bozec, S., Theurey, P., Grouin, J., Chevalier, C., Dagorn, P. G., Moller, D. E., & Cusi, K. J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100474 · Cited by 57
Garzia, E., Galiano, V., Marfia, G., Navone, S. E., Grossi, E., & Marconi, A. M. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00876-0 · Cited by 57
“Hyperinsulinemia aggravates the hormonal and ovulatory dysfunctions [5] by inducing an excessive production of androgens and a decrease in serum sex hormone binding globulin (SHBG).”
BackgroundXia, W., Cai, Y., Zhang, S., & Wu, S. (2023) · BMC Public Health · doi:10.1186/s12889-023-16813-2 · Cited by 57
Oberg, E., Gidlöf, S., Jakson, I., Mitsell, M., Tollet Egnell, P., & Hirschberg, A. L. (2019) · Clinical Endocrinology · doi:10.1111/cen.13919 · Cited by 43
Li, X., Zhu, Q., Wang, W., Qi, J., He, Y., Wang, Y., Lu, Y., Wu, H., Ding, Y., & Sun, Y. W. (2018) · The FASEB Journal · doi:10.1096/fj.201802829r · Cited by 57
Shaaban, Z., Khoradmehr, A., Amiri‐Yekta, A., Nowzari, F., Shirazi, M. R. J., & Tamadon, A. (2021) · Genetics Research · doi:10.1155/2021/7781823 · Cited by 57
“Because the reproductive and metabolic implications are mainly observed in the first-class relatives, PCOS is considered as a genetic disorder [6].”
BackgroundInfluentialThe neuroendocrine genesis of polycystic ovary syndrome: A role for arcuate nucleus GABA neurons
Moore, A. M., & Campbell, R. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.002 · Cited by 57
The post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“PCOS is a common hyperandrogenic disorder affecting about 6% of women of reproductive age, principally characterized by hyperandrogenism and associated with insulin resistance and metabolic syndrome (reviewed by Diamanti-Kandarakis and Dunaif, 2012 and by Legro et al., 2013).”
BackgroundKarakas, S. E., Perroud, B., Kind, T., Palazoglu, M., & Fiehn, O. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.04.003 · Cited by 50
“Keywords: n-3 Polyunsaturated fatty acids Plasma metabolites Branched chain amino acids Insulin resistance PCOS”
BackgroundInfluentialFurtado, C. L. M., Ramos, F. K. P., Kogure, G. S., Santana-Lemos, B. A. A., Ferriani, R. A., Calado, R. T., & dos Reis, R. M. (2016) · Reproductive Sciences · doi:10.1177/1933719115611753 · Cited by 56
“The PCOS group (n 1⁄4 45) was classified using the Rotterdam consensus, based on at least 2 of the following 3 features: chronic anovulation, hyperandrogenism (clinical or biochemical), and polycystic ovaries on ultrasound,(5) with 4 different phenotypes being possibly observed: (1) hyperandrogenism and anovulation, (…”
MethodYAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.
Wang, C., Jeong, K., Jiang, H., Guo, W., Gu, C., Lu, Y., & Liang, J. (2016) · PubMed Central · Cited by 57
Kominiarek, M. A., Jungheim, E. S., Hoeger, K. M., Rogers, A. M., Kahan, S. I., & Kim, J. J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.02.006 · Cited by 56
“Women with PCOS have a high predisposition to IR, seen in both normalweight and obese individuals [26].”
BackgroundChanges in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS
Hoover, S. E., Gower, B. A., Cedillo, Y. E., Chandler-Laney, P. C., Deemer, S. E., & Goss, A. M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab028 · Cited by 39
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., & Arslanian, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01958 · Cited by 55
“PCOS is characterized not only by hormonal and reproductive disorders but also by a cluster of metabolic abnormalities driven by insulin resistance and hyperinsulinemia (28).”
Backgrounddos Santos, Í. K., Nunes, F. A. S. D. S., de Queirós, V. S., Cobucci, R. N., Dantas, P. B., Soares, G. M., Cabral, B. G. D. A. T., Maranhão, T. M. D. O., & Dantas, P. M. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245023 · Cited by 55
“Thus, this reduction in HOMA-IR in the studied population may be efficient for treating the syndrome and its possible consequences, since women with PCOS have a higher prevalence of insulin resistance (IR), hyperinsulinemia, dyslipidemia, and metabolic syndrome [39].”
BackgroundBaldani, D. P., Škrgatić, L., Kasum, M., Zlopaša, G., Oguić, S. K., & Herman, M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1534096 · Cited by 56
Ablating astrocyte insulin receptors leads to delayed puberty and hypogonadism in mice
Manaserh, I. H., Chikkamenahalli, L. L., Ravi, S., Dube, P. R., Park, J. J., & Hill, J. W. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000189 · Cited by 56
McAllister, J. M., Han, A. X., Modi, B. P., Teves, M. E., Mavodza, G. R., Anderson, Z. L., Shen, T., Christenson, L. K., Archer, K. J., & Strauss, J. F. (2019) · Endocrinology · doi:10.1210/en.2019-00013 · Cited by 56
“com/endo Endocrinology, August 2019, 160(8):1964–1981 doi: 10.”
BackgroundInfluentialHaudum, C., Lindheim, L., Ascani, A., Trummer, C., Horvath, A., Münzker, J., & Obermayer-Pietsch, B. (2020) · Nutrients · doi:10.3390/nu12061622 · Cited by 49
Huang, J., Zhao, J., Geng, X., Chu, W., Li, S., Chen, Z., & Du, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.008 · Cited by 55
“In PCOS, a post-binding defect is observed in receptor signaling, likely owing to inactivated IRS1 that selectively affects metabolic action in classic insulin target tissues and in the ovary.(68) We found that CCNL expression levels were also increased in patients with PCOS exhibiting higher BMI and higher HOMAIR val…”
BackgroundDiabetes and the Female Reproductive System
Nandi, A. A., & Poretsky, L. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.007 · Cited by 55
Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?
Hashim, H. A. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.09.015 · Cited by 55
“Insulin-sensitizing agents, especially metformin, have therefore been used as a treatment option in women with PCOS (Diamanti-Kandarakis and Dunaif, 2012; Fox and Ryan, 2002).”
BackgroundGenetic Markers of Polycystic Ovary Syndrome: Emphasis on Insulin Resistance
Shaikh, N. J., Dadachanji, R., & Mukherjee, S. (2014) · International Journal of Medical Genetics · doi:10.1155/2014/478972 · Cited by 54
“These studies offer an advantage at controlling population stratification, hypothesis generation, and detection of novel susceptibility loci [95].”
BackgroundSpironolactone in the treatment of polycystic ovary syndrome
Armanini, D., Andrisani, A., Bordin, L., & Sabbadin, C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1215430 · Cited by 53
Kazemi, M., Jarrett, B. Y., Vanden Brink, H., Lin, A. W., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2020) · Nutrients · doi:10.3390/nu12071953 · Cited by 53
Androulakis, I. I., Kandaraki, E., Christakou, C., Karachalios, A., Marinakis, E., Paterakis, T., & Diamanti‐Kandarakis, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12447 · Cited by 41
Self-citationPutative role for insulin resistance in depression risk in polycystic ovary syndrome
Greenwood, E. A., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.019 · Cited by 53
Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens
Cardozo, L. L. Y., Romero, D. G., & Reckelhoff, J. F. (2017) · Physiology · doi:10.1152/physiol.00030.2016 · Cited by 53
“Hyperinsulinemia also contributes to hyperandrogenemia by decreasing the hepatic synthesis of sex hormone binding globulin (SHBG), leading to increased free androgen levels (22).”
BackgroundLipodystrophic syndromes: From diagnosis to treatment
Sollier, C., Vatier, C., Capel, É., Lascols, O., Auclair, M., Janmaat, S., Fève, B., Jéru, I., & Vigouroux, C. (2019) · Annales d Endocrinologie · doi:10.1016/j.ando.2019.10.003 · Cited by 53
“Polycystic ovarian syndrome, or ovarian hyperthecosis, evolve in parallel to the insulin resistance due to the activation of the ovarian IGF1 receptor in response to massive circulating insulin concentrations [24,25].”
BackgroundHulchiy, M., Nybacka, Å., Sahlin, L., & Hirschberg, A. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3803 · Cited by 53
Ding, Y., Jiang, Y., Zhu, M., Zhu, Q., He, Y., Lu, Y., Wang, Y., Qi, J., Feng, Y., Huang, R., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.960274 · Cited by 52
Huang, C.-C., Tien, Y.-J., Chen, M.-J., Chen, C.-H., Ho, H.-N., & Yang, Y.-S. (2015) · Human Reproduction · doi:10.1093/humrep/dev010 · Cited by 43
“…abnormalities, but it is also strongly associated with metabolic aberrations, including dyslipidemia, insulin resistance (IR), abdominal obesity, type II diabetes mellitus (T2DM) and hypertension (HTN) (Chen et al., 2007; Moran et al., 2010; Diamanti-Kandarakis and Dunaif, 2012; Wild et al., 2010).”
BackgroundInfluentialTorchen, L. C., Idkowiak, J., Fogel, N. R., O'Neil, D. M., Shackleton, C. H. L., Arlt, W., & Dunaif, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3926 · Cited by 49
Self-citationN-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications
Salek, M., Clark, C. C. T., Taghizadeh, M., & Jafarnejad, S. (2019) · EXCLI journal · doi:10.17179/excli2019-1534 · Cited by 34
Non-alcoholic fatty liver disease in polycystic ovary syndrome women
Won, Y. B., Seo, S. K., Yun, B. H., Cho, S., Choi, Y. S., & Lee, B. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-86697-y · Cited by 53
Papalou, O., Livadas, S., Karachalios, A., Tolia, N., Kokkoris, P., Tripolitakis, K., & Diamanti‐Kandarakis, E. (2014) · HORMONES · doi:10.14310/horm.2002.1563 · Cited by 52
“It is a heterogeneous disorder characterized by ovulatory dysfunction, clinical and biochemical hyperandrogenemia and polycystic ovaries and is associated with various metabolic abnormalities, including obesity, insulin resistance, metabolic syndrome, type 2 diabetes mellitus and dyslipidemia, thus increasing the life…”
BackgroundSelf-citationRamezani Tehrani, F., Minooee, S., & Azizi, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0094 · Cited by 51
Soave, I., Occhiali, T., Assorgi, C., Marci, R., & Caserta, D. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1729108 · Cited by 51
Salehi, S., Allahverdy, J., Pourjafar, H., Sarabandi, K., & Jafari, S. M. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10223-5 · Cited by 51
Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome
Çalan, M., Yılmaz, Ö., Küme, T., Kocabaş, G. Ü., Senses, P. Y., Senses, Y. M., Temür, M., & Çalan, Ö. G. (2016) · Endocrine · doi:10.1007/s12020-016-0875-z · Cited by 51
Lerchbaum, E., Theiler‐Schwetz, V., Giuliani, A., & Obermayer-Pietsch, B. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1035 · Cited by 51
Jensterle, M., Herman, R., & Janež, A. (2022) · Biomedicines · doi:10.3390/biomedicines10081989 · Cited by 50
“Linking PCOS to inherited insulin resistance that is frequently aggravated by obesity-induced insulin resistance paved the way for trials of diabetes drugs in PCOS [6,7].”
BackgroundNybacka, Å., Hellström, P. M., & Hirschberg, A. L. (2017) · Clinical Endocrinology · doi:10.1111/cen.13427 · Cited by 50
Alzueta, E., & Baker, F. C. (2023) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2023.06.003 · Cited by 50
Xu, Q., Zhang, J., Lu, Y., & Wu, L. Y. (2024) · iScience · doi:10.1016/j.isci.2024.108783 · Cited by 50
“16 In turn, HA impairs insulin sensitivity and exacerbates visceral obesity.”
BackgroundAdvances in polychlorinated biphenyls-induced female reproductive toxicity
Wu, C., Du, X., Liu, H., Chen, X., Ge, K., Meng, R., Zhang, Z., & Zhang, H. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170543 · Cited by 50
Çalan, Ö. G., Çalan, M., Senses, P. Y., Kocabaş, G. Ü., Ozden, E., Sari, K. R., Kocar, M., İmamoğlu, Ç., Senses, Y. M., Bozkaya, G., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13157 · Cited by 50
Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
Behboudi-Gandevani, S., Ramezani Tehrani, F., Hosseinpanah, F., Khalili, D., Cheraghi, L., Kazemijaliseh, H., & Azizi, F. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.046 · Cited by 46
LncRNA BANCR participates in polycystic ovary syndrome by promoting cell apoptosis
Yang, R., Chen, J., Wang, L., & Deng, A. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9793 · Cited by 50
“It is known that abnormal gonadotropin levels may cause anovulation and hyperandrogenism (4).”
BackgroundNegative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis
Piovezan, J. M., Premaor, M. O., & Comim, F. V. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz020 · Cited by 50
Rani, R., Hajam, Y. A., Kumar, R., Bhat, R. A., Rai, S., & Rather, M. A. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100161 · Cited by 50
Metadata
- Authors
- Diamanti-Kandarakis, E., & Dunaif, A.
- Affiliations
- Medical School, University of Athens (E.D.-K.), Athens GR-14578, Greece
- Northwestern University (US)
- ORCID
- Dunaif, Andrea
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-10-12
- Volume
- 33
- Issue
- 6
- Pages
- 981-1030
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC5393155
- OpenAlex
- W1967263394
- Semantic Scholar
- b2b7fa060bf61f261edf17bef51cbbbd222742e0
- Cited by
- 1,947
- References
- 628
- Citations by year
- 2026: 183 · 2025: 178 · 2024: 182 · 2023: 221 · 2022: 191 · 2021: 184 · 2020: 136 · 2019: 140 · 2018: 108 · 2017: 97 · 2016: 96 · 2015: 92 · 2014: 91 · 2013: 43 · 2012: 4
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073411)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405, R01HD057223, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, insulin resistance, insulin receptor signaling, MAPK/ERK pathway, skeletal muscle insulin sensitivity, ovarian steroidogenesis, ovulation, brain insulin signaling, body weight regulation, insulin-sensitizing drugs, androgens, developmental origins of health and disease, fetal growth restriction, genetic susceptibility loci, type 2 diabetes risk, lean PCOS
- MeSH terms
- Female, Humans, Insulin Resistance, Phenotype, Polycystic Ovary Syndrome, Reproduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.